Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease.
Saved in:
| Title: | Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease. |
|---|---|
| Authors: | Siler TM; Midwest Chest Consultants, PC, Saint Charles, MO, USA., Rheault T; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA., Reyner D; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA., MacDonald-Berko M; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA., Davidson J; Stat One LLC, Cary, NC, USA., Rickard K; Verona Pharma, a Subsidiary of Merck & Co., Inc., Rahway, NJ, USA. |
| Source: | International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2026 Feb 10; Vol. 21, pp. 589655. Date of Electronic Publication: 2026 Feb 10 (Print Publication: 2026). |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Case Reports; Clinical Trial |
| Journal Info: | Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1178-2005 |
|---|---|
| DOI: | 10.2147/COPD.S589655 |
